We are submitting the copy of Physical intimation made to the shareholders whose email address was not registered

Kilitch Drugs (India) Ltd. KI 1“ August, 2026 To, To, The Manager - Corporate Relationship The Manager - Corporate Compliance Dept. National Stock Exchange of India Ltd BSE Limited Exchange Plaza, Plot No.C-1, P. J. Towers, Dalal Street G Block, BKC, Bandra (E), Fort, Mumbai - 400 001 Mumbai 400 051 Scrip Code: BSE - 524500 Scrip Code: NSE - KILITCH Sub: Letter to Shareholders — Annual Report FY 2025-26 Dear Sir, Pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company has issued letters to shareholders providing the weblink of the website from where the Annual Report for FY 2025-26 and Notice of AGM can be accessed to those whose e-mail addresses are not registered with the Company/Registrar & Transfer Agent/Depository Participants. The letter issued in this regard is enclosed herewith for your reference. We request you to kindly take the same on record and acknowledge the receipt. Thanking you, For Kilitch Drugs (India) Limited Mukund Mehta Managing Director Ny we 3991:3008 = WHO CERTIFIED ono. Corporate office : 37/39, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai - 400 088. e Tel.: +91-22-6121 4100 « Fax : +91-22-6703 1658 Registered Office & Manufacturing unit : G-301/2, M.1.D.C., T.7.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705. Maharashtra. « GIN: L24239MH1992PLC066718 « Tel.; +91-22-6299 6300 « Fax : +91-22-2768 0912 « E-mail : info@kilitch.com « Website : www.kilitch.com Kilitch Drugs (India) Limited CIN: L24239MH1992PLC066718 Registered Office: C-301/2, M.I.D.C. TTC Industrial Area, Pawane Village, Navi Mumbai - 400 705. Tel: 022 61214100 Website: www.kilitch.com E-mail: pushpanyoupane@kilitch.com Ref: Date: 01.08.2026 Shareholder Name: Folio No: XXXXXXXX Address: Sub: Notice of 34 Annual General Meeting (AGM) of Kilitch Drugs (India) Limited and Annual Report for the Financial Year 2025-26. We are pleased to inform you that the 34 Annual General Meeting (‘AGM’) of the Members of Kilitch Drugs (India) Limited (‘the Company’) is scheduled to be held on Thursday, 27" August, 2026 at 9:00 a.m. (IST) through Video Conferencing ('VC') facility / Other Audio Visual Means ('OAVM'). As per Regulation 36 (1) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ((SEBI Listing Regulations, 2015’), as amended, the web-link, including the exact path, where complete details of the Annual Report are available is required to be sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or MUFG Intime India Private Limited (Formerly Link Intime India Private Limited), Registrar & Share Transfer Agent (RTA) of the Company. Accordingly, the web-link, including the exact path where complete details of the Annual Report for the Financial Year 2025-26 are available at: Website: www.kilitch.com Exact path of Annual Report 2025-26: https://kilitch.com/investor-relations/ This letter 1s being sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or RTA of the Company as on the cut-off date as on 24" July, 2026. This is also a reminder to update KYC details pursuant to SEBI Master Circular No. SEBI/HO/MIRSD/POD- 1/P/CIR/2024/37 dated May 07, 2024, and to dematerialise physical securities. The circular issued by SEBI mandates all the listed companies to record PAN, Address with PIN code, Mobile Number, Bank Account details, Specimen Signature and choice of Nomination of security holders holding securities in physical mode. While updating Email ID is optional, the security holders are requested to register email id also to avail online services. This is applicable for all security holders holding securities 1n physical mode. The formats for choice of Nomination and Updation of KYC details viz; Forms ISR-1, ISR-2, ISR-3, SH-13, SH-14 and SEBI circulars are available on our website as mentioned below: https://www.in.mpms.mufg.com > Resources > Downloads > KYC > Formats for KYC. The aforesaid SEBI Circular also mandates that security holders holding in physical mode whose folios do not have PAN, Choice of Nomination, Contact details, Bank Account details and Specimen Signature updated, shall be eligible for any payment including dividend, interest or redemption payment in respect of such folios, only through electronic mode with effect from April 1, 2024. Should you have any queries, please feel free to contact our investor relations department at [pushpanyoupane@kilitch.com] or [02261214100]. Moreover, you are also requested to update your e-mail address at the earliest either through your depository participants for electronic holding or send a communication to us / our RTA to facilitate the updation to continue receiving all important information & documents thereafter and encourage Green Initiative. Thanking you, Yours faithfully, For Kilitch Drugs (India) Limited Sd/- Company Secretary